{"version":"1.0","type":"link","title":"Response to Letter to the Editor: \"In Patients Receiving Pembrolizumab, Adverse Effects on the Pituitary Gland, Heart and Kidneys Must Be Excluded\".","author_name":"Inoue S 외","author_url":"https://prs-insight.online/author/Inoue%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/170986","thumbnail_width":1200,"thumbnail_height":630}